Coston McIsaac & Partners Sells 924 Shares of Colgate-Palmolive (NYSE:CL)

Coston McIsaac & Partners decreased its position in shares of Colgate-Palmolive (NYSE:CL) by 13.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,966 shares of the company’s stock after selling 924 shares during the quarter. Coston McIsaac & Partners’ holdings in Colgate-Palmolive were worth $541,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in CL. Peak Financial Advisors LLC purchased a new stake in shares of Colgate-Palmolive during the 4th quarter worth $1,315,000. Gordian Advisors LLC purchased a new stake in shares of Colgate-Palmolive during the third quarter valued at about $602,000. Carrera Capital Advisors lifted its position in shares of Colgate-Palmolive by 23.1% during the third quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock valued at $4,066,000 after buying an additional 7,353 shares during the last quarter. Fiduciary Alliance LLC bought a new stake in shares of Colgate-Palmolive in the 4th quarter valued at about $4,066,000. Finally, Vontobel Holding Ltd. grew its position in shares of Colgate-Palmolive by 224.6% in the 3rd quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company’s stock worth $82,626,000 after buying an additional 550,750 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Down 0.2 %

Shares of Colgate-Palmolive stock opened at $89.65 on Thursday. The firm has a 50-day simple moving average of $91.67 and a two-hundred day simple moving average of $97.34. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. Colgate-Palmolive has a fifty-two week low of $82.68 and a fifty-two week high of $109.30. The company has a market cap of $73.24 billion, a P/E ratio of 25.69, a price-to-earnings-growth ratio of 3.59 and a beta of 0.44.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.23%. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on CL shares. StockNews.com downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. UBS Group lowered their price objective on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a research report on Thursday, January 16th. Wells Fargo & Company reduced their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. TD Cowen decreased their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Finally, Barclays decreased their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday, January 17th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $102.00.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. The trade was a 55.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.34% of the stock is owned by corporate insiders.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.